Zhu et al. [65] demonstrated that the inhibitory effects of KMP on proliferation are greater in estrogen receptor-positive breast cancer cells (BT474 cells) compared to estrogen receptor-negative cells (MDA-MB-231 cells). Here, ESR1 is linked to breast carcinoma.